Lucintel Newsletter

Business News by Lucintel

Bookmark and Share

Wednesday, July 30, 2025

Lucintel Forecasts the Global DL-3-Hydroxybutyrate Calcium Market to Grow with a CAGR of 5.4% from 2025 to 2031

According to a market report by Lucintel, the future of the global DL-3-hydroxybutyrate calcium market looks promising with opportunities in the health product and food additive markets. The global DL-3-hydroxybutyrate calcium market is expected to grow with a CAGR of 5.4% from 2025 to 2031. The major drivers for this market are the rising demand for ketone supplements, the growing awareness of mental & physical health benefits, and the increasing prevalence of obesity & metabolic disorders.

A more than 150-page report to understand trends, opportunity and forecast in global DL-3-hydroxybutyrate calcium market to 2031 by type (purity≥98% and purity<98%), application (health products, food additives, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World).

Lucintel forecasts that, within the type category, purity ≥ 98% is expected to witness higher growth over the forecast period.

Within the application category, health product is expected to witness higher growth.

Download sample by clicking on DL-3-hydroxybutyrate calcium market.

In terms of region, North America is expected to witness the highest growth over the forecast period.

Caihe Biotech, Create Company, GIHI CHEMICALS, Shanghai KangXin Chemical, Anhui Integrity Biopharm are the major suppliers in the DL-3-hydroxybutyrate calcium market.

This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at helpdesk@lucintel.com. To get access of more than 1000 reports at fraction of cost visit Lucintel's Analytics Dashboard.

About Lucintel

At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.

Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email:
roy.almaguer@lucintel.com
Tel. +1-972-636-5056

Explore Our Latest Publications

Psilocybin Assisted Therapy Market

Proton Therapy Synchrotron Market

Proton Therapy Accelerator Market

Nitric Oxide Therapy System Market

Natural Killer Cell Therapy Market

No comments:

Post a Comment